Literature DB >> 11930976

Intraportal hepatocyte transplantation in the pig: hemodynamic and histopathological study.

Maurizio Muraca1, Danielle Neri, Anna Parenti, Paolo Feltracco, Anna Granato, Maria Therese Vilei, Chiara Ferraresso, Roberto Ballarin, Gian Eros Zanusso, Gianpiero Giron, Jacek Rozga, Giorgio Gerunda.   

Abstract

BACKGROUND: Hepatocyte transplantation is an attractive treatment for various liver diseases. The intraportal route of transplantation is favored, but little information is available on the possible adverse effects in this technique. We investigated the influence of intraportal loads of hepatocytes on portal, pulmonary, and systemic hemodynamics in 13 pigs.
METHODS: Under general anesthesia, pigs were provided with an arterial line, a Swan-Ganz catheter, and two intraportal catheters, one for cell infusion and one for heparin infusion and portal pressure measurement. Pig hepatocytes were infused at a rate of 25 million cells/min.
RESULTS: The first six animals were used to develop the infusion technique. In the last seven animals, portal pressure increased linearly with cell load upon infusion of 400-2400 x 10(6) hepatocytes (r(2)=0.704;P<0.05). Portal flow measured by Doppler sonography decreased by 23-66% below basal values. An inverse linear relationship was found between portal pressure and portal flow (r(2)=0.679; P<0.05), portal flow approaching zero for portal pressure >40 mmHg. Pulmonary arterial pressure increased by 11-62%. AST increased up to 10-fold, and platelets decreased by 22-58%. Hepatocytes-containing thrombi were present in segmental and in smaller portal branches. Hepatocytes were always identified in lung sinusoids 48 hr after infusion, and a small basal pulmonary infarction was found in one animal.
CONCLUSION: . These data suggest that up to 2.4% of total hepatocyte mass can be infused in this large animal model. However, the risk of significant thrombotic complications should be considered for clinical applications.

Entities:  

Mesh:

Year:  2002        PMID: 11930976     DOI: 10.1097/00007890-200203270-00010

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  The fate of autologous hepatocytes transplanted into spleen, pancreas, mesentery, stomach, and small bowel wall in pigs.

Authors:  Meindert N Sosef; Robert B J De Bondt; Anne Bosma; Cora De Bruijn; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

2.  Migration of human umbilical cord blood cells into rat liver.

Authors:  Alaa Ismail; Ehsan Hassan; Mohamed I Seleem; Medhat Hassan; Firas Z ElDeen; Ahmed Salah; Abdulhafez A Selim
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

3.  Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models.

Authors:  Clara T Nicolas; Raymond D Hickey; Kari L Allen; Zeji Du; Rebekah M Guthman; Robert A Kaiser; Bruce Amiot; Aditya Bansal; Mukesh K Pandey; Lukkana Suksanpaisan; Timothy R DeGrado; Scott L Nyberg; Joseph B Lillegard
Journal:  Surgery       Date:  2018-06-06       Impact factor: 3.982

4.  In vivo imaging of transplanted hepatocytes with a 1.5-T clinical MRI system--initial experience in mice.

Authors:  Alain Luciani; Alexandre Parouchev; Pierre Smirnov; Gustavo Braga; Claire Wilhelm; Florence Gazeau; Lyes Boudechiche; Aurore L'hermine-Coulomb; Ibrahim Dagher; Dominique Franco; Alain Rahmouni; Michèle Hadchouel; Anne Weber; Olivier Clement
Journal:  Eur Radiol       Date:  2007-10-05       Impact factor: 5.315

5.  Monitoring of Liver Cell Transplantation in a Preclinical Swine Model Using Magnetic Resonance Imaging.

Authors:  Nathanael Raschzok; Ulf Teichgräber; Nils Billecke; Anja Zielinski; Kirsten Steinz; Nora N Kammer; Mehmet H Morgul; Sarah Schmeisser; Michaela K Adonopoulou; Lars Morawietz; Bernhard Hiebl; Ruth Schwartlander; Wolfgang Rüdinger; Bernd Hamm; Peter Neuhaus; Igor M Sauer
Journal:  Cell Med       Date:  2010-12-22

Review 6.  Liver cell transplantation for the treatment of inborn errors of metabolism.

Authors:  J Meyburg; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

7.  Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model.

Authors:  Nelson K F Chen; Jen San Wong; Irene H C Kee; Siang Hui Lai; Choon Hua Thng; Wai Har Ng; Robert T H Ng; Soo Yong Tan; Shu Yen Lee; Mark E H Tan; Jaichandran Sivalingam; Pierce K H Chow; Oi Lian Kon
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

8.  The Regenerative Effect of Portal Vein Injection of Liver Organoids by Retrorsine/Partial Hepatectomy in Rats.

Authors:  Tomonori Tsuchida; Soichiro Murata; Koichiro Matsuki; Akihiro Mori; Megumi Matsuo; Satoshi Mikami; Satoshi Okamoto; Yasuharu Ueno; Tomomi Tadokoro; Yun-Wen Zheng; Hideki Taniguchi
Journal:  Int J Mol Sci       Date:  2019-12-26       Impact factor: 5.923

9.  Investigation of Clinical Safety of Human iPS Cell-Derived Liver Organoid Transplantation to Infantile Patients in Porcine Model.

Authors:  Tomonori Tsuchida; Soichiro Murata; Shunsuke Hasegawa; Satoshi Mikami; Shin Enosawa; Huai-Che Hsu; Akinari Fukuda; Satoshi Okamoto; Akihiro Mori; Megumi Matsuo; Yumi Kawakatsu; Hitomi Matsunari; Kazuaki Nakano; Hiroshi Nagashima; Hideki Taniguchi
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.